Clinical trials: Cystic Fibrosis - Complete
Healthy Volunteer - Complete, Cystic Fibrosis - Complete
Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis
Part 1 of this trial will enroll healthy volunteers into a single ascending dose (SAD), multiple ascending dose (MAD), and Food Effect (FE) treatment groups.
- Trial name
- NCT03251092
- Testing
- PTI-808, PTI-428, PTI-801
- Where
- 48 sites in United States, Australia and 7 more
- Volunteers
- 179 people, healthy volunteers welcome
- Sponsor
- Proteostasis Therapeutics, Inc.